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Background: Ribosomal protein L30 belongs to the L7Ae family of RNA-binding proteins, which recognize diverse
targets. L30 binds to kink-turn motifs in the 28S ribosomal RNA, L30 pre-mRNA, and mature L30 mRNA. L30 has a
noncanonical function as a component of the UGA recoding machinery that incorporates selenocysteine (Sec) into
selenoproteins during translation. L30 binds to a putative kink-turn motif in the Sec Insertion Sequence (SECIS)
element in the 3’ UTR of mammalian selenoprotein mRNAs. The SECIS also interacts with SECIS-binding protein 2
(SBP2), an essential factor for Sec incorporation. Previous studies showed that L30 and SBP2 compete for binding to
the SECIS in vitro. The SBP2:SECIS interaction has been characterized but much less is known about how L30
recognizes the SECIS.
Results: Here we use enzymatic RNA footprinting to define the L30 binding site on the SECIS. Like SBP2, L30
protects nucleotides in the 5’ side of the internal loop, the 5’ side of the lower helix, and the SECIS core, including
the GA tandem base pairs that are predicted to form a kink-turn. However, L30 has additional determinants for
binding as it also protects nucleotides in the 3’ side of the internal loop, which are not protected by SBP2. In
support of the competitive binding model, we found that purified L30 repressed UGA recoding in an in vitro
translation system, and that this inhibition was rescued by SBP2. To define the amino acid requirements for
SECIS-binding, site-specific mutations in L30 were generated based on published structural studies of this protein in
a complex with its canonical target, the L30 pre-mRNA. We identified point mutations that selectively inhibited
binding of L30 to the SECIS, to the L30 pre-mRNA, or both RNAs, suggesting that there are subtle differences in
how L30 interacts with the two targets.
Conclusions: This study establishes that L30 and SBP2 bind to overlapping but non-identical sites on the SECIS.
The amino acid requirements for the interaction of L30 with the SECIS differ from those that mediate binding to
the L30 pre-mRNA. Our results provide insight into how L7Ae family members recognize their cognate RNAs.
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Eukaryotic ribosomal protein L30 is a component of the
large ribosomal subunit. L30 has no prokaryotic ortholog
but the gene is essential in yeast [1]. Cryo-electron
microscopy studies of the wheat germ and canine 80S
ribosomes revealed that L30 is located in a eukaryotic-* Correspondence: driscod@ccf.org
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reproduction in any medium, provided the orspecific bridge between the large and small subunits
[2,3]. The interaction of L30 with the 60S ribosome is me-
diated primarily through binding of the protein to a kink-
turn motif in helix 58 of the large rRNA [2,4]. L30 also
binds to a kink-turn in the 5’ untranslated region (UTR)
of its cognate pre-mRNA and the mature spliced mRNA
to auto-regulate its own expression at the level of pre-
mRNA splicing or mRNA translation, respectively [5-8].
The repertoire of L30 functions was expanded by the
discovery that the protein is involved in the mechanism
that recodes the UGA stop codon as selenocysteine
(Sec) during selenoprotein synthesis [9]. In humans,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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play critical roles in anti-oxidant defense, thyroid hor-
mone metabolism, immunity, and development [10,11].
Sec incorporation at the UGA/Sec codon is dependent
on a stem-loop structure, the Selenocysteine Insertion
Sequence (SECIS) element, which is found in the 3’
UTR of eukaryotic selenoprotein mRNAs. This structure
consists of two helices separated by an internal loop with
an apical loop or bulge at the top (see Figure 1A). The
core of the SECIS contains a quartet of non-Watson-
Crick base pairs, including two sheared G•A tandem
base pairs which are characteristic of kink-turn motifs.
Based on structure probing and computer modeling,
Walczak et al. proposed a three-dimensional structure of
the SECIS in which the RNA is kinked at the internal
loop, exposing the sheared G•A tandem base pairs in the
SECIS core to the solvent [12]. The SECIS core, which is
essential for Sec incorporation, is required for binding of
two proteins, L30 and SECIS-binding protein 2 (SBP2)
[9,13-16]. In vitro studies support a model in which the
two proteins bind to the SECIS element independently,
and likely sequentially [9]. SBP2 has been shown to re-
cruit the Sec-tRNASec:EFSec complex, bind to the ribo-
some, and induce a conformational change in the A site
[17-19]. However, the exact functions of SBP2 and L30
in UGA recoding have not been fully defined, and alter-
native models have been proposed [9,17,18].
A prerequisite for elucidating the mechanism of Sec
incorporation is a detailed understanding of the molecu-
lar basis for protein:SECIS interactions. L30 and SBP2
are both members of the L7Ae family of RNA-binding
proteins. In addition to the founding member archaeal
ribosomal protein L7Ae, this family includes other
eukaryotic ribosomal proteins as well as proteins in-
volved in RNA processing, ribonucleoprotein assembly,
and termination of protein synthesis [20,21]. The L7Ae
family members share a similar RNA-binding domain
and characteristically bind to kink-turn motifs in their
cognate RNA. However, the kink-turn does not repre-
sent a single structural motif [22]. Each protein in the
L7Ae family has a unique RNA-binding specificity,
which allows it to distinguish its cognate RNA from
other kink-turn containing transcripts in the cell. Indir-
ect evidence from our lab suggests that the SECIS core
is part of a noncanonical kink-turn, which may explain
why the SECIS is bound by L30 and SBP2, but not by
other proteins in the L7Ae family [9].
We, and others have characterized the SBP2:SECIS
interaction at the molecular level, although no structural
studies on the complex have been performed to date.
Based on RNA footprinting experiments, SBP2 binds to
both sides of the SECIS core, as well as to the 5’ strand
of the internal loop and lower helix [14]. The upper
helix and a large internal loop in the SECIS may also beimportant for recognition by SBP2 [23]. Mutational ana-
lysis of SBP2 revealed that the L7Ae motif is necessary
but not sufficient to mediate SECIS-binding and that
additional amino acids in a K-rich region N-terminal to
this motif are required [24,25]. The SBP2:SECIS inter-
action is critical for human health as mutations in either
the SBP2 binding site or in the SBP2 RNA-binding do-
main result in a reduction in selenoprotein synthesis and
a variety of phenotypes [26-28].
In contrast to SBP2, much less is known about how
L30 recognizes the SECIS. We previously showed that
L30 binds to SECIS elements from multiple selenopro-
tein mRNAs [9], but the actual L30 binding site has not
been defined. Compared to SBP2, L30 is a relatively
small protein (11 kDa) and it lacks a K-rich region.
Structural studies of L30 in a complex with its cognate
target, the stem-loop from the L30 pre-mRNA, have de-
fined the RNA-binding interface of the protein [29,30].
However, it is not known whether the same amino acids
mediate binding to the SECIS. In this study, we used
RNA footprinting and site-directed mutagenesis to iden-
tify nucleotides and amino acids that are important for
the L30:SECIS interaction.
Results
Defining the L30 binding site by RNA footprinting
Eukaryotic SECIS elements are stem-loop structures
containing two highly conserved motifs that are essential
for Sec incorporation, namely the SECIS core and the
AAR motif in an apical bulge or loop. The SECIS elem-
ent from the rat Phospholipid Hydroperoxide Glutathi-
one Peroxidase (PHGPx) mRNA is shown in Figure 1A.
We previously showed that binding of L30 to the
PHGPx SECIS was abrogated by mutations in the shea-
red G•A tandem base pairs in the SECIS core, but not
by deletion of the AAR motif [9]. In order to define the
L30 binding site on the SECIS, we used enzymatic RNA
footprinting. The 32P-labeled PHGPx SECIS RNA was
incubated in the presence or absence of purified rat L30.
The native RNA and RNA:protein complexes were then
partially digested with different ribonucleases and ana-
lyzed by electrophoresis. Regions of cleavage and protec-
tion were identified by comparing samples with RNA
sequencing reactions (G and C +U) and alkali ladders. A
schematic illustrating the results is shown in Figure 1A
and a gel representative of 3 independent experiments is
shown in Figure 1B.
The cleavage results with the native RNA are consist-
ent with the published structure of the PHGPx SECIS,
which was determined by enzymatic and chemical prob-
ing [31]. RNase T1, which cleaves after single-stranded
G bases, cleaved the native PHGPx SECIS RNA in the
apical region, both strands of the SECIS core, and the 3’
side of the internal loop (Figure 1B). Similar results were
Figure 1 RNA footprinting of the L30:SECIS complex. A. The structure of the SECIS element from the rat PHGPx mRNA is shown. Boxes and
circles indicate nucleotides that are protected from cleavage by RNase T1 and RNase A, respectively. B. The 5’ end-labeled PHGPx SECIS was
incubated in the absence or presence of L30 (0.75 or 1.5 μM). The reactions were then partially digested with RNase T1, A, or V1 as indicated. The
products were analyzed by denaturing gel electrophoresis. The sequencing (G and C + U) and alkali ladders are shown in the left lanes. The
numbers to the left of the gel indicate the positions of G nucleotides using the numbering in (A). The bars on the right indicate the different
regions of the SECIS element. The gel is a representative example from 3 independent experiments.
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http://www.biomedcentral.com/1471-2199/14/12obtained when the SECIS was partially digested with
RNase A, which cleaves at single-stranded C and U
bases. Cleavage by RNase A was detected in the 5’ side
of the SECIS core, the apical loop, as well as both sides
of the internal loop. Both RNase A and T1 cleaved at
the base of helix 1 (nucleotides 121-128) suggesting that
this region may breathe due to imperfect base pairing.
RNase V1, which cleaves in double-stranded regions,
cleaved at multiple positions in helix 1 and helix 2. We
also observed faint V1 digestion in the large internal
loop, which suggests that this region may occasionally
form an alternate structure.
When the SECIS was incubated with 0.75 or 1.5 μM
L30, there was a marked reduction in cleavage by RNase
T1 on both sides of the SECIS core (G41, G82, G84) and
along the 3’ side of the internal loop 2 (G85, G90, G91,
G93, G95). We were unable to achieve full protection by
increasing the amount of L30 in the binding reaction, most
likely due to the high on/off rate of the L30:SECIS com-
plex as determined by Surface Plasmon Resonance (data
not shown). G53 and G68 in the apical region and G122,
G125, G127, and G128 at the base of helix 1 were not re-
producibly protected by L30 from RNase T1 cleavage.
When the L30:SECIS complexes were partially diges-
ted with RNase A, there was a reduction in cleavage in
the 5’ side of the internal loop and SECIS core (bases
36-38 and 40) and the 3’ side of the internal loop (bases
92, 94, 96). Other bases in the internal loop (C87, C88,
U89) and the base of helix 1 were still cleaved by RNase
A in the presence of L30. Similarly, the binding of L30
did not protect nucleotides in helix 1 or helix 2 from
RNase V1 cleavage. Taken together, our results show
that binding of L30 protects nucleotides in the SECIS
core and in the 5’ and 3’ sides of the internal loop. WePHG
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Figure 2 The U40C mutation abrogates L30 binding. A. Schematic illus
as determined by RNA footprinting. The position of the U40C point mutati
the 32P-labeled wild-type PHGPx SECIS or the U40C mutant RNA, which we
After RNase digestion, the products were analyzed by SDS-PAGE and autorpreviously showed that SBP2 interacts with both sides of
the SECIS core, the 5’ strand of the internal loop, and
the 5’ strand of helix 1, but not with the 3’ side of the in-
ternal loop [14]. Thus the two proteins bind to similar
but not identical regions of the SECIS, as illustrated in
Figure 2A.
L30 represses UGA recoding in vitro and this inhibition is
rescued by SBP2
The fact that the SBP2 and L30 binding sites overlap is
consistent with our earlier finding that purified recom-
binant L30 and SBP2 compete for binding in vitro to an
isolated SECIS in the absence of other factors [9]. To
test whether this competition could occur during trans-
lation, we used a luciferase reporter construct and a
modified rabbit reticulocyte lysate (RRL) system. This
assay has been previously validated to be specific for
UGA recoding [32]. The Luc/UGA/PHGPx reporter
RNA contains a UGA/Sec codon at position 258 in the
open reading frame and the PHGPx SECIS in the 3’
UTR. Since RRL contains very little SBP2, we added re-
combinant SBP2-CT, which represents the C-terminal
half of the protein and encodes all known functions of
SBP2. Translation assays were supplemented with puri-
fied 70 nM SBP2-CT to be within the linear range of the
assay. Reactions were performed in the absence or pres-
ence of increasing amounts of L30, and the products
were analyzed for luciferase activity.
As shown in Figure 3A (top panel), the addition of ex-
ogenous L30 inhibited recoding of Luc/UGA/PHGPx in
a dose-dependent manner. This effect is codon-specific
and SECIS-dependent as the inhibition was not observed
when the reactions were primed with a Luc/UGU/
PHGPx reporter construct, which contains a UGU/CysPx RNA: Wild-type
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Figure 3 Repression of UGA recoding by L30 is rescued by SBP2. A. In vitro UGA recoding assays were performed using a luciferase reporter
RNA that contains UGA (top panel) or UGU (bottom panel) at position 258 of the coding region, fused to either the PHGPx or TR1 SECIS element
as indicated. Translation assays were performed in the presence of increasing amounts of L30 as indicated. The products were analyzed for
luciferase activity using a luminometer, and the results are expressed as means ± SEM. Statistical significance is indicated by ** (p < 0.01) and ***
(p < 0.001). B. UGA recoding assays with the luc/UGA/TR1 reporter construct were performed with a constant amount of L30 (44 pmol/reaction)
and increasing amounts of SBP2 as indicated. The products were analyzed as described in (A).
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RNA that lacks a SECIS element (data not shown). The
addition of L30 also repressed UGA recoding directed
by the SECIS element from Thioredoxin Reductase 1
(TR1) (Figure 3A, top panel). We hypothesized that the
exogenous L30 protein interacted with the SECIS and
prevented binding of SBP2, which is limiting in our
translation system. To test this competitive model, we
added increasing amounts of SBP2 to the translation re-
action while keeping the amount of L30 constant. As
shown in Figure 3B, the inhibitory effect of L30 on re-
coding from the TR1 SECIS was rescued by the addition
of SBP2. Similar results were obtained using the Luc/
UGA/PHGPx construct (data not shown). Taken to-
gether, these results demonstrate that SBP2 and L30 can
functionally compete in an in vitro translation system.
Mutations in L30 inhibit SECIS-binding
The L7Ae family members are functionally diverse and
recognize a variety of targets. A number of these RNA:
protein complexes have been analyzed at the structural
level [29,30,33-36]. An emerging theme from these stud-
ies is that the L7Ae family members bind to their differ-
ent cognate RNAs in a similar manner. Therefore, we
designed site-directed mutations based on the solutionstructures of yeast L30 in complex with the stem-loop
from the L30 pre-mRNA target, which were solved by
NMR spectroscopy and x-ray crystallography [29,30]. An
induced fit model was proposed in which L30 folds into
an α/β/α sandwich, with the three loops at the end of
the sandwich in direct contact with the RNA [29,30].
We generated alanine point mutations in these function-
ally important regions, including L29 in the first loop of
the α/β/α sandwich, L35 and K36 in the α2 region, and
K87, Y89, and V91 in the α4–β4 loop (Figure 4A). We
also mutated M108 and E110 in the C-terminal region,
as these residues are present in L30 sequences from
higher eukaryotes and SBP2, but not in S12, an L7Ae
family member that does not bind the SECIS [9].
The wild-type and mutant L30 proteins were analyzed
for purity by SDS-PAGE (Figure 4B) and for RNA-binding
activity using RNA Electrophoretic Mobility Shift Assays
(REMSA). The rat PHGPx SECIS element and the stem-
loop structure from the yeast L30 pre-mRNA (subse-
quently referred to as L30 RNA) were used as 32P-labeled
probes. As shown in Figure 5A, the wild-type protein
bound to the SECIS in a dose-dependent manner with an
apparent KD of ~ 0.49 μM, which is comparable to what
was previously reported [9]. The affinity of L30 for the
L30 RNA was several-fold higher with a KD of 0.17 μM
L30(1) VAAKKTKKSLESINSRL-QL--VM-KSG-KYVLGYKQTLKMIRQGKAKLVILANNC-PALRKSEI-E- 
SBP2(636) ACVTGLLKELVRFQDRMYQKDPVKAKTKRRLVLGLREVLKHLKLRKLKCIIISPNCEKTQSKGGLDDT 
L30(61) YYAML--A-KTGVH-HYSGNNIELGTACGKYYRVCTLAIID-PGDSDIIRSMPEQTGEK
SBP2(704) LHTIIDCACEQNIPFVFALNRKALGRSLNKAVPVSIVGIFSYDGAQDQFHKMVELTMAA
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Figure 4 Mutational analysis of L30. A. A schematic illustrating the primary sequences and predicted secondary structures of L30 and SBP2.
The position numbers refer to the rat protein sequences. The L7Ae conserved RNA-binding domain is underlined and the conserved signature
amino acid motifs for L30 and SBP2 are boxed as described in [37]. Arrows indicate the amino acids in L30 that were mutated to alanine. B. The
wild-type and mutant L30 protein were expressed in bacteria, purified and analyzed by SDS-PAGE and Coomassie Blue staining. The molecular
weight markers are shown in the left lane of each gel.
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teins, using a protein concentration at which 50% of the
probe was bound by the wild-type L30. Representative
REMSAs are shown in Figure 6A, and the graphs of the
results from 5 and 3 independent experiments, respect-
ively, are presented in Figure 6B.
We found that the amino acid requirements for L30
binding to the SECIS and the L30 RNA are similar but not
identical. The Y89A mutant protein was the most defect-
ive, with 32% and 37% binding to the SECIS and L30
RNA, respectively, compared to the wild-type protein. We
also identified two mutations that selectively inhibited
binding of L30 to one target RNA but not the other. As
shown in Figure 6B, the K87 mutation in rat L30 reduced
binding to the SECIS by 40% but had little effect on the
L30:L30 RNA interaction. In contrast the K36A mutant
protein was more impaired in its ability to interact with
the L30 RNA (reduced by 60%) than the SECIS (reduced
by 22%). There was a slight (14%) reduction in binding of
the L35A mutant to both the SECIS and L30 RNA, butonly the latter result was statistically significant (Figure 6B).
The other mutants, L29A, V91A, M108A, and E110A,
were comparable to the wild-type protein with respect to
their ability to bind to both targets.
We also analyzed several mutant L30 proteins for their
ability to inhibit UGA recoding in our in vitro transla-
tion system. As shown in Figure 7, the L29A and
M108A mutant proteins, which have wild-type levels of
SECIS-binding activity, reduced UGA recoding by ~50%,
similar to wild-type L30. However, the K36A and Y89A
mutants, that are defective in SECIS-binding, only re-
duced UGA recoding by 9% and 4% respectively Thus,
there was a correlation between the ability of L30 to
bind to the SECIS and repress recoding in vitro.
A naturally occurring SECIS mutation inhibits L30 binding
One interesting finding from the footprinting experi-
ments was that L30 protected U40 in the SECIS core. A
previous study identified a naturally occurring U to C
point mutation at this position in the Selenoprotein N
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Figure 5 REMSA analysis of the RNA-binding activity of L30. A. The 32P-labeled PHGPx SECIS was incubated with increasing amounts of L30
as indicated. The complexes were analyzed by native gel electrophoresis (top panel). The percent SECIS bound at each protein concentration is
shown graphically (bottom panel). B. REMSA analysis was performed as described in (A) except that the stem-loop from the L30 pre-mRNA
(L30 RNA) was used as the probe.
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Figure 6 Point mutations in L30 affect RNA-binding activity. A. Representative REMSA analysis of the 32P-labeled PHGPx SECIS (top panel) or
L30 RNA (bottom panel). The RNA probes were incubated in the absence or presence of wild-type and mutant L30 proteins as indicated. The
positions of the free probes and protein:RNA complexes are indicated. B. Graphical representation of REMSA results for L30 binding to the SECIS
(top panel) or L30 RNA (bottom panel) from 5 or 3 independent experiments, respectively. The results are expressed relative to the activity of the
wild-type protein, which is expressed as 100%. Statistical significance is shown by asterisks, with * (p < 0.05), ** (p < 0.01) and *** (p < 0.001).
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Figure 7 L30 repression of UGA recoding correlates with SECIS-
binding. UGA recoding assays were performed using the luc/UGA/
TR1 reporter construct as described in the legend to Figure 4A.
Reactions contained either no L30 or 44 pmol of wild-type or
mutant L30 proteins. Results are expressed as means ± SEM.
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http://www.biomedcentral.com/1471-2199/14/12(SelN) SECIS element from a patient with a mild form
of rigid spine muscular dystrophy [16]. SelN expression
was impaired in this patient, and this mutation was
shown to abrogate binding of SBP2 to the SelN and
PHGPx SECIS elements [13,16]. We hypothesized that
the mutant RNA may also be defective in the L30:SECIS
interaction, as L30 and SBP2 have overlapping binding
sites (Figure 2A). The 32P-labeled wild-type and U40C
mutant SECIS RNAs were incubated with increasing
amounts of purified L30 protein. The RNA:protein com-
plexes were UV cross-linked, digested with RNase A,
and analyzed by SDS-PAGE electrophoresis and auto-
radiography. As shown in Figure 2B, L30 cross-linked to
the wild-type SECIS but not to the U40C mutant RNA.
Thus, defects in selenoprotein synthesis in patients with
mutant SECIS elements may not be solely due to an im-
paired SBP2:SECIS interaction.
Discussion
As members of the L7Ae family, L30 and SBP2 share a
similar RNA-binding domain. However, there are im-
portant differences in how the two proteins interact with
the SECIS. Our RNA footprinting experiments revealed
that the binding site of L30 centers on the SECIS core
and internal loop. L30 protects nucleotides in the SECIS
core, including the Gs in the two, sheared G•A tandem
base pairs that form the putative kink-turn motif. The
protein also protects many of the nucleotides in the in-
ternal loop. Thus, the L30 binding site described here
overlaps with the regions that have been shown to be
protected by SBP2 binding, including the SECIS core
and 5’ side of the internal loop [14]. In addition to shar-
ing these common nucleotide requirements, L30 and
SBP2 each have unique determinants for binding to the
SECIS. We show here that L30 protects the 3’ side of the
internal loop, which is distinct from the known SBP2binding site [14]. Likewise, SBP2 protects nucleotides in
the upper part of helix 1, which are not part of the L30
binding site.
The fact that the binding sites of L30 and SBP2 over-
lap provides a molecular explanation for our earlier find-
ing that the two proteins cannot interact simultaneously
with the SECIS [9]. Our results also have implications
for interpreting defects in SBP2:SECIS interactions that
are associated with human disease. A naturally occurring
point mutation in a highly conserved nucleotide in the
SelN SECIS that was previously shown to disrupt SBP2
binding and selenoprotein synthesis also inhibited bind-
ing of L30. Thus, it is important to keep in mind that
mutant SECIS elements may be defective in more than
one function.
To date, the SECIS element is the only known cognate
RNA for SBP2. In contrast, L30 binds to several other
kink-turn containing targets, including the L30 pre-
mRNA, L30 mature mRNA, and 28S ribosomal RNA.
As the structure of the SBP2:SECIS complex has not
been solved, we turned to the NMR and co-crystal struc-
tures of the yeast L30 protein in a complex with the L30
pre-mRNA to guide our mutational analysis. We chose
to design site-specific mutations in regions defined as
the RNA-binding interface for the L30:L30 pre-RNA
interaction. Interestingly, the crystal structure of a 60S
ribosomal subunit from the fresh water ciliate Tetrahy-
mena thermophila was recently published, and it is the
first such structure from an organism that synthesizes
selenoproteins [4]. Using the published coordinates, we
utilized several molecular modeling programs to analyze
the structure of L30 on the ribosome where it is bound
to helix 58 of the 26S rRNA (unpublished observations).
T. Thermophila L30 appears to use a similar RNA-
binding interface to bind to a kink-turn in helix 58, as
the yeast protein uses to bind to the L30 pre-mRNA.
Thus, we expected that some of the same amino acids
might also be important for the L30:SECIS interaction.
Indeed, the Y89A mutant protein was defective in bind-
ing to both the SECIS and the L30 RNA, its canonical
target. This residue is equivalent to F85 in the yeast pro-
tein, where it is the most prominent amino acid contact
in the L30:L30 pre-mRNA complex [29,30]. Based on
mutagenesis studies, an aromatic group is required at
this position for binding of the yeast protein to the L30
RNA [29], and a similar requirement may be true for the
L30:SECIS interaction.
Unlike Y89, mutagenesis of K36 and K87 had selective
effects on the interaction of L30 with the two target
RNAs. The K36A mutation had a greater inhibitory
effect on binding of the protein to the L30 RNA than to
the SECIS. The equivalent amino acid in the yeast pro-
tein, K32, did not directly contact the RNA in the NMR
and crystal structures of the L30:L30 RNA complex [30].
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amino acid could play an important role by neutralizing
the negatively charged phosphate backbone [29,30]. We
also found that mutagenesis of L35, which is also in the α2
helical region, modestly reduced binding inhibition to
both targets. This result was only statistically significant
for the L30:L30 RNA interaction, however.
In contrast, we found that K87 is important for the
L30:SECIS interaction, but is dispensable for binding to
the L30 RNA. This was a particularly interesting result
as K87 is part of a signature motif that has been identi-
fied for L30 [37]. It is well established that each L7Ae
family member has a unique RNA-binding specificity.
However the basis for this selectivity has not been well
understood as the proteins share a relatively conserved
RNA-binding domain. An elegant study by Gagnon et al.
recently identified five signature amino acids flanking
this region that are unique to each family member [37].
One amino acid is N-terminal to the RNA-binding do-
main whereas the other four residues comprise a motif
that is C-terminal to the domain. The C-terminal motif
in particular is quite different between family members,
with respect to the structure and chemical properties of
the conserved amino acids. Functional evidence was pro-
vided for the L7Ae and 15.5 kDa proteins, showing that
the unique conserved amino acids are necessary al-
though not sufficient to mediate specific binding to the
appropriate cognate RNA. The consensus N-terminal
amino acid for L30 and SBP2 is a basic residue, K26 in
rat L30 and R665 in rat SBP2 (Figure 5A). K87, which is
important for the L30:SECIS interaction, is the first
amino acid in KYYR, the C-terminal signature motif for
L30 [37]. This residue is also highly conserved in SBP2
(K733 in rat SBP2, see Figure 5), where it is part of this
protein’s signature motif KAVP [37]. Interestingly, K is
not present in the first position of the signature motifs
for other eukaryotic L7Ae family members, including
L7Ae, 15.5 kDa protein, rpL7a, Nhu2p, and Rpp38p [37].
The unique signature motifs that have evolved in L30
and SBP2 may explain the ability of these proteins to
bind to the SECIS, which contains a large internal loop
and a non-canonical kink-turn motif. As discussed
above, the binding of L30 to the SECIS and the L30
RNA depends on Y89, which is the third amino acid in
the KYYR motif. SBP2 has a V at this position, and mu-
tational analysis of human SBP2 showed that this amino
acid is important for the SBP2:SECIS interaction [38].
The fact that the signature motifs for L30 and SBP2 are
not identical is consistent with the unique RNA-binding
specificities of the two proteins, as L30 has been shown
to bind to multiple cognate RNAs whereas the only
known target for SBP2 is the SECIS element. An impor-
tant future direction will be to solve the structures of
the L30:SECIS and SBP2:SECIS complexes.Conclusions
The study presented here provides new insight into how
ribosomal protein L30 recognizes the SECIS element.
Our findings suggest that there are subtle differences in
how L30 interacts with its different cognate RNAs. The
results expand our knowledge of how L7Ae family mem-
bers recognize different RNA targets.Methods
Constructs
The wild-type rat PHGPx SECIS and U40C mutant
constructs were previously described [13]. The rat
PHGPx SECIS elements of 129 nucleotides and 102
nucleotides, which were used for RNA footprinting
and REMSA analysis respectively, are described in
[39]. The stem-loop L30 pre-mRNA was generated by
annealing primers (Additional file 1: Table S1) in 10
mM NaCl and slow cooling the sample from 95°C to
room temperature. The luc/UGA258/PHGPx and luc/
UGA258/TR1 constructs were described in [40]. The
L30 cDNA was amplified from rat liver cDNA (BD
Bioscience) by polymerase chain reaction (PCR) and
the products cloned into the Champion™ pET200 Dir-
ectional TOPO® vector (Life Technologies) down-
stream of an N-terminal His6 tag. Mutants of L30 were
constructed using the QuikChange Site-directed muta-
genesis method (Stratagene), using the appropriate
mutagenic primers (Additional file 1: Table S1). All
constructs were verified by Sanger sequencing.RNA synthesis
Plasmid DNAs were linearized and used as templates for
in vitro transcription. For UV cross-linking and REMSA
analyses, RNAs were synthesized in the presence of
[α32P] UTP (800 Ci/mmole; Perkin Elmer Easy Tides)
using the RiboMAX™ Large Scale RNA Production Sys-
tems (T7) (Promega). Transcripts were purified using or-
ganic extraction followed by gel filtration using Micro
Bio-Spin 30 Columns (BioRad). L30 RNA was gel puri-
fied and resuspended in 10 mM Tris HCl, pH 7.5. Un-
labeled RNAs were prepared using the AmpliScribe T7-
Flash Transcription kit (Epicentre) and purified as de-
scribed above. For RNase footprinting experiments, cold
synthetic transcripts were dephosphorylated with
SuperSAP (Affymetrix), purified, and resuspended in
nuclease-free water. Dephosphorylated transcripts were
end-labeled in the presence of [γ32P] ATP (3000 Ci/
mmole; Perkin Elmer Easy Tides) and T4 PNK (NEB) at
20 units/pmole RNA. The transcripts were gel purified
on 8% acrylamide (19:1)/7M urea gels and eluted in 10
mM Tris HCl, pH 7.5, 1 mM EDTA, pH 8, 300 mM
NaAc, pH 5.5 at 4°C overnight. Purified RNA was stored
in 10 mM Tris HCl, pH 7.5 at -20°C.
Bifano et al. BMC Molecular Biology 2013, 14:12 Page 10 of 12
http://www.biomedcentral.com/1471-2199/14/12Protein purification
Recombinant rat L30 was expressed in BL21 Star (DE3)
cells (Invitrogen). IPTG was added to 1 mM and the cul-
ture was grown at 37°C for 3 hr. The cells were harvested
at 4°C, and the pellets washed with 1X PBS and frozen on
dry ice. Purification buffers (PB) contained 20 mM
HEPES-HCl, pH 8.0 and the indicated amounts of NaCl
and imidazole. The frozen cell pellet was re-suspended in
20 ml of PB/0.2 M NaCl/20 mM imidazole, to which 60
kU rlysozyme (Novagen), 500 U of Benzonase Nuclease
(Novagen) and two Complete, Mini, EDTA-free Protease
Inhibitor Cocktail tablets (Roche) were added. The cells
were further lysed by sonication on ice. The insoluble ma-
terial was removed by two centrifugations of the lysate at
~16,000 × g for 15 min at 4°C. The cell lysate was filtered
through a 0.45 μM filter and passed across a HisTrap TM
FF crude column (GE Healthcare) using an AKTA Purifier
(UPC-900) (GE Healthcare). The resin was sequentially
washed with PB/0.2 M NaCl/20 mM imidazole, PB/1 M
NaCl/20 mM imidizole, and PB/0.2M NaCl/40 mM imid-
azole. The protein was eluted with PB/0.2 M NaCl/250
mM imidazole and collected in 1 or 2 ml fractions. Frac-
tions containing the pure protein were combined and dia-
lyzed against 1 L of PB/0.2 M NaCl buffer for 2 hr at 4°C,
which was then repeated with fresh buffer for an add-
itional 2 hr at 4°C. The protein was dialyzed against PB/0.2
M NaCl containing 50% glycerol for 18 hr at 4°C. The dia-
lyzed protein was aliquoted and stored at −70°C. Recom-
binant SBP2-CT was purified as previously described [40].
RNase footprinting
End-labeled 32P-labeled PHGPx SECIS RNA was heated
to 95°C and slow cooled to room temperature. The RNA
(2.5 nM) was incubated in L30 binding buffer (30 mM
Tris HCl, pH 8.0, 75 mM KCl, 5 mM MgCl2, 1 mM
DTT, 0.04 μg/μL BSA (NEB), 10% glycerol, and 50 ng/
μL yeast tRNA) with or without rat L30 protein (0.75 or
1.5 μM as indicated) at 30°C for 15 min. Reactions were
cooled to room temperature over a 2 min period and
then placed at 22°C for 2-5 min. The indicated amounts
of RNase T1, A, or V1 (Ambion) were added to
the appropriate samples and incubated at 22°C for 5
min. Enzymatic reactions were quenched with 20 μL
Inactivation/Precipitation buffer (Ambion) and purified
according to manufacturer’s directions. Samples were
resuspended in 10 μL of dye-less loading buffer (95%
formamide, 18 mM EDTA, and 0.025% SDS), heat-
denatured at 95°C for 5 min, and separated in a denatur-
ing 8% (19:1) polyacrylamide/7 M urea gel. The dried
gels were visualized with a phosphorimager or on film.
Sequencing ladders were prepared by incubating end-
labeled 32P-labeled PHGPx SECIS RNA (2.5 nM) in 1X
Sequencing Buffer (Ambion) supplemented with 50 ng/
μL yeast tRNA. The RNAs were incubated at 50°C for 5min, cooled to 22°C and the indicated amounts of RNase
T1, A, or V1 added. The samples were incubated,
quenched, and purified as described above. Alkali lad-
ders were prepared by incubating end-labeled 32P-la-
beled PHGPx SECIS RNA (2.5 nM) in 100 mM NaOH,
2 mM EDTA, pH 8.0, and 2 μg/μL yeast tRNA at 37°C
for 3 min, to which 0.2 M Tris HCl, pH 8.0 (final) was
added. The samples were frozen on dry ice and com-
bined with an equal volume of denaturing loading buffer
(10 M urea, 1X TBE).
UV cross-linking
The 32P-labeled PHGPx SECIS or U40C mutant RNAs
(10 fmol) were incubated in buffer containing 0.7X PBS,
11 mM DTT, 250 ng/μL yeast tRNA and RNAguard
(Amersham). The indicated amounts of L30 were added
last and the reactions incubated at 37°C for 30 min. The
samples were irradiated on ice at 254 nm for 10 min in
Costar 96-well polystyrene plates (Corning, Inc) using a
Bio-Rad GS Genelinker. The RNA was digested with 20
U of RNase A (Fermentas) at 37°C for 1 hr. The samples
were separated on a 15% SDS–PAGE (37.5:1) gel. The
gels were dried and visualized using a phosphorimager.
UGA recoding assays
In vitro transcribed RNAs (100 ng) were added to an
in vitro translation reaction (25 μL) containing rabbit re-
ticulocyte lysate (Promega), complete amino acid mix
(Promega), Protector RNase Inhibitor (Roche), and 70 nM
purified recombinant SBP2-CT protein. Purified recom-
binant L30 protein was added as indicated. Reactions were
incubated at 30°C for 30 min and placed on ice for 15
min. Aliquots of the translation products (2.5 μL) were
then added to the luciferase substrate (50 μL) in a well of
a Microlite 1 microtiter plate (Thermoscientific). Lumi-
nescence was measured in 10 sec intervals using a Victor3
Multilabel Counter (Perkin Elmer).
RNA Electrophoretic Mobility Shift Assays (REMSA)
The 32P-labeled SECIS RNA (10 fmol) was incubated in
L30 binding buffer (30 mM Tris HCl, pH 8.0, 75 mM
KCl, 5 mM MgCl2, 1 mM DTT, 0.04 μg/μL BSA (NEB),
10% glycerol, 50 ng/μL yeast tRNA, and 0.2 U/μL Pro-
tector RNase Inhibitor (Roche)) with the indicated final
concentration of L30 protein at 30°C for 15 min. Sam-
ples were transferred to ice and then separated in non-
denaturing polyacrylamide gels, either 6% (19:1) or 8%
(29:1), in 0.5X TBE gel at 4°C. The dried gels were
visualized with a Phosphorimager or on film. The 32P-la-
beled yeast L30 RNA was incubated in 350 mM KCl, 30
mM Tris HCl, 8.0, and 10 mM DTT at 60°C and allowed
to slow cool to room temperature as previously de-
scribed [41]. The binding reactions were then set-up and
processed as described above. The reactions were
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0.5X TBE gel at 4°C.
Statistical analysis
Data were analyzed using GraphPad Prism software. The
results are expressed as means +/- standard error of the
mean (S.E.M). Statistical significance is indicated as *
(P < 0.05), ** (P < 0.01), or *** (P < 0.001).
Additional file
Additional file 1: Table S1. Oligonucleotides used in this study.
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